<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mp ids='MP_0003674'>Oxidative stress</z:mp> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> are important elements in the pathogenesis of <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to evaluate the role of both and of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity in the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence in <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In mucosal specimens from 59 patients grouped as having symptomatic <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo>, <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e>, or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the esophagus, plus controls, we measured myeloperoxidase activity, superoxidase dismutase activity, <z:chebi fb="0" ids="16856">glutathione</z:chebi> content, and total aromatic DNA adducts </plain></SENT>
<SENT sid="3" pm="."><plain>To evaluate blood vessel densities and angioarchitecture, we used immunohistochemistry and a modified whole-mount technique </plain></SENT>
<SENT sid="4" pm="."><plain>Sections were stained with endothelium-specific markers and smooth muscle cell actin </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The reflux disease-<z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence revealed progressively increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> (increased myeloperoxidase activity), decreased <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="0" ids="16856">glutathione</z:chebi> content), and simultaneous formation of DNA adducts </plain></SENT>
<SENT sid="6" pm="."><plain>Pooled data show a negative correlation between <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and DNA adducts (-0.28; P =.05) </plain></SENT>
<SENT sid="7" pm="."><plain>This sequence was also characterized by increased intensity in microvessels and an increasing percentage of immature blood vessels </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, the whole-mount technique offered 3-dimensional evidence that the rich new vascular bed is highly abnormal, with repeated twists, <z:e sem="disease" ids="C0011119" disease_type="Disease or Syndrome" abbrv="">bends</z:e>, or turns, even in nonmalignant <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Increased <z:mp ids='MP_0003674'>oxidative stress</z:mp>, decreased <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity, and a negative correlation between <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and DNA adduct formation indicate a link between <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of <z:e sem="disease" ids="C1258085" disease_type="Disease or Syndrome" abbrv="">Barrett epithelium</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Simultaneously, this transformation acquires angiogenic capacity, strong neovascularization, and abnormal angioarchitecture </plain></SENT>
</text></document>